In the increasingly competitive lubricating jelly market, brands must find cost-saving opportunities at the source. Many new brands are often slowed down by tens of thousands of dollars in design fees and high prototyping costs during the startup phase. In fact, leveraging mature OEM factories' "zero-cost design, zero-cost prototyping" strategy has become a recognized cost-cutting tool in the industry. This not only reduces expenses but also deeply shares R&D resources and supply chain efficiency, allowing startup funds to be precisely spent on driving traffic conversion.
"Zero-cost design" means that brands can directly access over 1,000 differentiated packaging options reserved by the factory. Whether it's medical syringes, vacuum pump bottles, or portable pouches, a professional team provides free visual extensions. "Zero-cost sampling" relies on the factory's library of over 2,000 verified mature formulas, allowing brands to receive samples in as fast as one working day, greatly shortening the new product launch cycle. Additionally, the core cost-reduction logic lies in "full qualification authorization." Brands do not need to invest millions or endure lengthy certification processes themselves; they can share the factory's US FDA 510K, EU CE, and domestic Class II medical device registrations. This combined approach saves an average of 200,000 yuan in R&D and design costs per project.
A low entry threshold does not mean low-quality output. Brand owners should choose leading companies with 16,000 square meters of modern factories that implement GMP pharmaceutical production standards. Supported by an automated daily capacity of 600,000 units, even startups can have medical-grade endorsements on par with major brands. This one-stop, highly efficient cooperation model is a shortcut for brands to enhance terminal premium capabilities and build global competitive advantages.
